Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA SUN PHARMA AUROBINDO PHARMA/
SUN PHARMA
 
P/E (TTM) x 12.5 55.9 22.4% View Chart
P/BV x 1.1 5.0 21.8% View Chart
Dividend Yield % 2.0 1.0 196.8%  

Financials

 AUROBINDO PHARMA   SUN PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
SUN PHARMA
Mar-22
AUROBINDO PHARMA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,064931 114.3%   
Low Rs584593 98.6%   
Sales per share (Unadj.) Rs400.3161.1 248.5%  
Earnings per share (Unadj.) Rs45.714.2 322.0%  
Cash flow per share (Unadj.) Rs64.923.1 280.8%  
Dividends per share (Unadj.) Rs9.0010.00 90.0%  
Avg Dividend yield %1.11.3 83.2%  
Book value per share (Unadj.) Rs419.4200.1 209.6%  
Shares outstanding (eoy) m585.942,399.34 24.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.14.7 43.5%   
Avg P/E ratio x18.053.7 33.6%  
P/CF ratio (eoy) x12.732.9 38.5%  
Price / Book Value ratio x2.03.8 51.6%  
Dividend payout %19.770.4 27.9%   
Avg Mkt Cap Rs m482,7991,827,693 26.4%   
No. of employees `000NANA-   
Total wages/salary Rs m34,50973,008 47.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,555386,545 60.7%  
Other income Rs m3,22614,374 22.4%   
Total revenues Rs m237,781400,919 59.3%   
Gross profit Rs m42,56653,150 80.1%  
Depreciation Rs m11,26521,437 52.5%   
Interest Rs m4861,274 38.2%   
Profit before tax Rs m34,04044,813 76.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,25610,755 67.5%   
Profit after tax Rs m26,78434,058 78.6%  
Gross profit margin %18.113.7 132.0%  
Effective tax rate %21.324.0 88.8%   
Net profit margin %11.48.8 129.6%  
BALANCE SHEET DATA
Current assets Rs m181,227350,150 51.8%   
Current liabilities Rs m81,560172,006 47.4%   
Net working cap to sales %42.546.1 92.2%  
Current ratio x2.22.0 109.2%  
Inventory Days Days25149 16.8%  
Debtors Days Days62100 62.4%  
Net fixed assets Rs m155,104318,882 48.6%   
Share capital Rs m5862,399 24.4%   
"Free" reserves Rs m245,174477,713 51.3%   
Net worth Rs m245,760480,112 51.2%   
Long term debt Rs m2,4922,299 108.4%   
Total assets Rs m336,331669,032 50.3%  
Interest coverage x71.036.2 196.1%   
Debt to equity ratio x00 211.7%  
Sales to assets ratio x0.70.6 120.7%   
Return on assets %8.15.3 153.5%  
Return on equity %10.97.1 153.6%  
Return on capital %13.99.6 145.6%  
Exports to sales %31.10-   
Imports to sales %11.90-   
Exports (fob) Rs m72,862NA-   
Imports (cif) Rs m27,965NA-   
Fx inflow Rs m77,245106,331 72.6%   
Fx outflow Rs m31,52471,874 43.9%   
Net fx Rs m45,72134,456 132.7%   
CASH FLOW
From Operations Rs m50,16589,845 55.8%  
From Investments Rs m-32,116-57,247 56.1%  
From Financial Activity Rs m-29,693-51,935 57.2%  
Net Cashflow Rs m-11,674-17,648 66.1%  

Share Holding

Indian Promoters % 48.8 54.5 89.5%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.0 35.6 106.6%  
FIIs % 21.4 16.0 133.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 45.5 105.8%  
Shareholders   358,459 643,512 55.7%  
Pledged promoter(s) holding % 15.9 2.5 627.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    PIRAMAL ENTERPRISES    


More on Aurobindo Pharma vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Sun Pharma Share Price Performance

Period Aurobindo Pharma Sun Pharma S&P BSE HEALTHCARE
1-Day -1.08% 1.20% 0.15%
1-Month -16.15% -1.97% -1.70%
1-Year -35.59% 30.73% -6.84%
3-Year CAGR 0.44% 32.48% 20.62%
5-Year CAGR -8.06% 13.44% 10.61%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 9.0 per share. This amounted to a Dividend Payout ratio of 19.7%.

Sun Pharma paid Rs 10.0, and its dividend payout ratio stood at 70.4%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 389 Points | Nifty Today Ends Below 18,500 | IT Stocks Witness Selling Pressure(Closing)

After opening the day on a flat note, Indian shares reversed early gains to end the day 0.6% lower.